NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
NovaBay Pharma (NBY) Reports Q1 Loss of $0.28/Share
May 9, 2019 5:08 PM EDTNovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $1.5 million, versus $2.9 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
... More